The designation LOC283143 Activators refers to a conceptual class of molecules hypothesized to interact with a genetic element labeled as LOC283143. The LOC prefix is typically used in genomic nomenclature to denote a specific locus within the genome, which might be associated with a gene of unknown function, a predicted protein that has not been experimentally confirmed, or potentially a non-coding RNA sequence. The number that follows, in this case, 283143, serves as a unique identifier allowing for the consistent reference to this locus across various genomic databases and research studies. If LOC283143 were proven to encode a protein, activators designed for this target would presumably aim to modulate the activity of this protein, perhaps by binding to it directly, by influencing its expression levels, or by interacting with associated regulatory elements.
In the theoretical pursuit of discovering and designing LOC283143 activators, researchers would first need to establish a foundational understanding of the protein or functional RNA encoded by this locus, including its role in cellular physiology and its molecular mechanisms of action. Assuming that LOC283143 encodes a protein, structural studies involving techniques like X-ray crystallography or cryo-electron microscopy might be utilized to elucidate the three-dimensional configuration of the protein. This structural information would be invaluable in identifying potential binding sites for activator molecules and in understanding the conformational changes that could increase the protein's activity. Following the identification of these sites, a variety of chemical entities could be synthesized and screened for their capacity to interact with and activate the protein. High-throughput screening techniques might be employed to assess the ability of thousands of compounds to modulate the activity of the LOC283143 protein product. Hits from these screens would then be subject to further analysis, including structure-activity relationship studies, to refine their potency and selectivity. This process would involve iterative rounds of chemical modification and subsequent testing to optimize the binding affinity and functional impact of these molecules. Advanced computational modeling might also be used to predict how these molecules interact with the protein, which could guide further refinement and the design of more effective activators for LOC283143.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
It may cause DNA demethylation, potentially leading to the upregulation of LINC00900 transcription. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to 5-Azacytidine, by inhibiting DNA methylation, it could increase the expression of LINC00900. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor that might relax chromatin structure and promote transcription of LINC00900. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
This compound has been shown to modulate gene expression, which could extend to the regulation of lncRNAs such as LINC00900. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Another HDAC inhibitor that could potentially enhance the transcription of LINC00900 by altering chromatin accessibility. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
As a transcriptional regulator, retinoic acid could potentially modulate the expression of genes and lncRNAs like LINC00900. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
It acts as an HDAC inhibitor and might increase the expression of LINC00900 through epigenetic modulation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium influences gene expression and could affect the transcription of LINC00900 through Wnt signaling pathways. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
As a mimic of cyclic AMP, it can activate protein kinase A and potentially upregulate the transcription of lncRNAs like LINC00900. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
A phytoestrogen known to act as an epigenetic modifier, which could potentially lead to changes in LINC00900 expression. | ||||||